GRIFOLS reported €136.88M in Net Income for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Alcon AG ALC:SW 168M 29M
Amadeus IT AMS:SM € 81.3M 102.4M
Amarin AMRN:US $ -31.56M 46.26M
Artemis Alpha ATS:LN -10252000 58.76M
AstraZeneca AZN:LN 386M 733M
Bayer BAYN:GR € 3291M 2130M
Fresenius FRE:GR € 413M 86M
Fresenius Medical Care FME:GR € 157.36M 71.38M
Galapagos GLPG:NA € -13.31M 29.66M
Genmab GEN:DC DK 465M 251M
GlaxoSmithKline GSK:LN 1802M 1053M
GRIFOLS GRF:SM € 136.88M 6.94M
H. Lundbeck A/S LUN:DC 412M 414M
Hikma Pharmaceutical HIK:LN 173M 75M
Inditex ITX:SM € 759M 15M
Merck MRK:GR € 881M 79M
Novartis NOVN:VX SF 2222M 14086M
Philips PHIA:NA € -152M 309M
William Demant Holding WDH:DC 1.34B 165M